Skip to main content
OpenTrials
Enrolling by Invitation

NCT Number: NCT06619171

Distress in Adolescents With Chronic Pain: Who is at Risk, When, and Why

Living with chronic pain can be tough for any young person. But while some young people may experience distressing thoughts, others may not. No young person should face these problems alone. So, it's important to better understand who might be more vulnerable to distress, when, and why. That way, healthcare professionals can be there for vulnerable youth when they need it most.

In total, 70 young people with chronic pain (aged 12-19 years) will be invited to take part. Over a 30-day period, they will answer a few questions about their pain and feelings five times per day (experience sampling part) and complete three detailed surveys (at the start, in the middle, and at the end).

This will help the investigators better understand how feelings of pain and distress might change over hours, days, and weeks. Plus, it might reveal which psychological and social factors might bring about these changes.

Answering these questions is vital as it will help healthcare professionals make sure vulnerable young people get the right care at the right time.

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Age range

12 year–19 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Bath Centre for Pain Services [BCPS], Bath, United Kingdom

Loading trial locations.

About this study

This study aims to address the following research questions:

  • What are the factors (moderators) that determine why some adolescents with chronic pain may experience suicidal distress but not others, and through which mechanisms (mediators) does chronic pain increase such distress over time?

Primary objective:

The investigators will use the repeated survey data (at day 0, 15, and 31):

  • To explore the extent to which pain interference (at baseline) is associated with suicidal distress (primarily hopelessness and entrapment, and secondarily suicidal and self-harm thoughts and behaviours), measured repeatedly over time.

Secondary objectives:

The investigators will use the experience sampling data (5x day/30 days: day 1-30) to explore:

  • how the relationship between pain interference and suicidal distress unfolds in the patient's daily life.
  • the moderators (collected at baseline, survey data) that determine why some young people with chronic pain may experience suicidal distress over time, but not others.
  • the mechanisms (experience sampling items) underpinning the potential relationship between pain interference and suicidal distress in the patient's daily life.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Participant is willing and able to give assent (aged 12-15 years) or informed consent (aged 16 years and older) for participation in the study,
  • Parent/guardian is willing to give informed consent for participants aged 12-15 years.
  • Adolescents aged 12 to 19 years.
  • Were accepted for assessment at a tertiary specialist paediatric pain service, indicating by definition that they experience long-standing, treatment-resistant chronic pain that is functionally interfering.
  • Able to read and converse fluently in English.
  • Participant is willing to install the m-Path app on a smartphone that runs on Android or iOS to complete the daily assessments. (Please note that a recent Ofcom report has shown that by the age of 12 years, 98% of young people in the UK have their own mobile phone, used by 93% to access social media apps or sites. This supports the nearly universal access of smartphones in this age group)

Exclusion criteria

  • If some serious acute pathology (e.g., infection, fracture, disease process (e.g., cancer with a potentially fatal trajectory)) or surgical procedure is the cause of the resulting pain complaint.
  • If the patient is too psychologically unstable to safely participate in this research, based on clinical judgment (e.g., experiences of acute psychosis)

Treatment and study plan

Primary outcomes

  1. Hopelessness

    Time frame: day 0 (baseline), 15 (interim survey), and day 31 (final survey)

    Hopelessness Scale for Children (HSC; 17 items) Response options: 1=True, 0=False (total score range: 0-17) The higher the score, the greater the hopelessness for the future.

  2. Entrapment

    Time frame: day 0 (baseline), 15 (interim survey), and day 31 (final survey)

    Short Defeat and Entrapment Scale (4 item entrapment subscale) Response options: 0 = not at all, 1 = a little bit, 2 = moderately, 3 = quite a bit, 4 = extremely like me (total score range: 0-16) Higher scores indicate greater feelings of entrapment.

  3. Suicidal and self-harm thoughts and behaviours

    Time frame: day 0 (baseline), 15 (interim survey), and day 31 (final survey)

    10 separate items on the presence/ absence of suicidal and self-harm thoughts and behaviours.

Secondary outcomes

  1. Hopelessness

    Time frame: day 1 to 30

    single item on hopelessness, assessed repeatedly (5x/30 days) via experience sampling (ESM) Response options: 1 (not at all) - 7 (very much). Higher scores indicate greater feelings of hopelessness

  2. Entrapment

    Time frame: day 1 to 30

    single item on entrapment, assessed repeatedly (5x/30 days) via experience sampling (ESM).

    Response options: 1 (not at all) - 7 (very much). Higher scores indicate greater feelings of entrapment.

  3. Suicidal and self-harm thoughts and behaviours

    Time frame: day 1 to 30

    single items on suicidal and self-harm thoughts and behaviours (5x/30 days), assessed repeatedly via experience sampling (ESM)

Sponsors and collaborators

Lead sponsor

University of Oxford

Other

Collaborators

  • Medical Research Foundation
  • Oxford University Hospitals NHS Trust
  • Royal United Hospitals Bath NHS Foundation Trust
  • Versus Arthritis

Registry information

Official study title

Suicidal Distress in Adolescents With Chronic Pain: Who is at Risk, When, and Why?

Important dates

Study start
2024
Primary completion
2025
Study completion
2026
First posted
Oct 1, 2024
Registry last updated
Oct 31, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.